ArticleFrontiers in oncology2025
Case Report: Two cases of bronchiolar adenoma/ciliated muconodular papillary tumor characterized by significant basal cell hyperplasia and squamous metaplasia.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Bronchiolar adenoma-like lesions with atypical features beyond the classic morphological spectrum: integrating histomorphology and molecular profiles.The Journal of pathology · 2026Article
- Bronchiolar adenoma and glandular papilloma/mixed squamous cell and glandular papilloma represent a continuous disease spectrum: revelations from combined histological and genetic analysis.Histopathology · 2026Article
- Multidimensional analysis of concurrent proximal bronchiolar adenoma and lung carcinoma.Journal of pathology and translational medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Bronchiolar adenoma/ciliated muconodular papillary tumor (BA/CMPT) is a rare benign pulmonary tumor from the bronchiolar epithelium. Histologically, it features a continuous basal cell layer and luminal cells. Its resemblance to invasive mucinous adenocarcinoma (IMA) and acinar adenocarcinoma complicates intraoperative frozen section diagnosis. When accompanied by extensive basal cell hyperplasia (BCH) and squamous metaplasia, it may mimic sclerosing pneumocytoma or adenosquamous carcinoma. This study presents two rare BA/CMPT cases with extensive BCH and squamous metaplasia. Case presentation: Case 1: A 62-year-old female was found to have a mixed ground-glass nodule in the right lower lung lobe on CT, raising suspicion of malignancy. She received a thoracoscopic segmentectomy. Histology revealed alveolar epithelial proliferation with extensive BCH and focal squamous metaplasia. Diagnosis: distal-type BA with BCH and squamous metaplasia.Case 2: A 67-year-old female had a solid nodule in the right lower lobe detected by CT, and a thoracoscopic wedge resection was performed. Histopathological examination revealed a lesion composed of ciliated and mucinous luminal cells overlying extensive BCH and areas of squamous metaplasia, with focal atypia observed in the basal cell layer. Diagnosis: proximal-type BA with BCH and atypical squamous metaplasia. IHC demonstrated that luminal cells in both cases expressed TTF-1, while basal cells expressed CK5/6, P63, and P40. Next-generation sequencing (NGS) did not identify any mutations or fusions in common driver oncogenes such as EGFR, BRAF, or KRAS. Postoperative follow-up showed no evidence of tumor recurrence or metastasis in either case. Conclusion: BA with extensive BCH and squamous metaplasia is rare and presents diagnostic challenges due to overlap with conditions such as sclerosing pneumocytoma, adenosquamous papilloma, adenosquamous carcinoma, mucoepidermoid carcinoma, and epithelial-myoepithelial carcinoma. Accurate diagnosis during intraoperative frozen section analysis is crucial for guiding appropriate surgical decision-making. IHC is essential for confirming the diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.